Use of first- and second-generation antipsychotic medications in older patients with schizophrenia in Asia (2001–2009)
Yu‐Tao Xiang(University of Macau), Naotaka Shinfuku(Seinan Gakuin University), Faith Dickerson(Sheppard Pratt Health System), Ee Heok Kua(National University of Singapore), Senta Fujii(Hyogo Institute for Traumatic Stress), Julie Kreyenbuhl(University of Maryland, Baltimore), Kang Sim(National University of Singapore), Michael Yong(Pacific Heart Institute), Chuanyue Wang(Capital Medical University), Edwin Lee(Center For Balanced Living), Yan-Ling He(Chinese University of Hong Kong), Tian-Mei Si(King George's Medical University), Kok‐Yoon Chee(Hospital Kuala Lumpur), Jitendra K. Trivedi, Mian-Yoon Chong(University of Maryland, Baltimore), Helen F.K. Chiu(Chinese University of Hong Kong), Shu-Yu Yang(Prince of Songkla University), Chay-Hoon Tan(National University of Singapore), Pichet Udomratn(Prince of Songkla University), E.-K. Chung(Chinese University of Hong Kong), Norman Sartorius(The Geneva Association)
Cited by 11
Related Papers
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|915
Reduced default mode network functional connectivity in patients with recurrent major depressive disorder
|Proceedings of the National Academy of Sciences|2019|865
The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|781
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003
|Schizophrenia Bulletin|2004|768
Improving polygenic prediction in ancestrally diverse populations
|Nature Genetics|2022|714